NPPB and hydrops fetalis: DAPA-HF studied dapagliflozin 10 mg once-daily versus placebo in 4744 patients NYHA II-IV HF with EF ≤40% and prespecified NT-proBNP thresholds for HHF or atrial fibrillation [25].